Development of nanoparticulate systems with action in breast and ovarian cancer: nanotheragnostics
F de Sousa Cunha, LN dos Santos Pereira… - Journal of Drug …, 2019 - Taylor & Francis
F de Sousa Cunha, LN dos Santos Pereira, TP de Costa e Silva, RA de Sousa Luz…
Journal of Drug Targeting, 2019•Taylor & FrancisThe use of nanoparticulate systems with action in breast and ovarian cancer has been
highlighted in recent years as an alternative to increasing the therapeutic index of
conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in
the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in
the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers,
which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the …
highlighted in recent years as an alternative to increasing the therapeutic index of
conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in
the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in
the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers,
which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the …
Abstract
The use of nanoparticulate systems with action in breast and ovarian cancer has been highlighted in recent years as an alternative to increasing the therapeutic index of conventional anticancer drugs. Thus, nanoparticles have advantageous characteristics in the treatment of cancer. Several nanocarriers of drugs and nanoparticles are described in the literature. The pharmacokinetics of the drugs can be modified by the use of nanocarriers, which in turn facilitate the specific delivery of the drug to the tumour cell. Therefore, the present work is a review that examines some nanosystems with nanoparticles for action in the treatment of breast cancer and ovarian cancer.
Taylor & Francis Online以上显示的是最相近的搜索结果。 查看全部搜索结果